Vistin Pharma
VISTN | OL
Overview
Corporate Details
- ISIN(s):
- NO0010734122
- LEI:
- 5967007LIEEXZXFQY092
- Country:
- Norway
- Address:
- Postboks 6735 Etterstad, 0609 Oslo
- Website:
- https://www.vistin.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
We are a Norwegian pharmaceutical company. As a dedicated European producer of high quality Metformin, we are well positioned to supply the growing global market. Vistin Pharma today produce about 10% of the world’s demand for Metformin HCl API and have in 2022 initiated a project to double the manufacturing capacity. Our Metformin is also available as direct compressible lubricated granules. Vistin Pharma Headquarter is located in Oslo, Norway. Our manufacturing facility is located in Kragerø, Norway. The facility is certified according to current Good Manufacturing Practice (cGMP) and successfully inspected by the US Food and Drug Administration (FDA). Vistin Pharma AS was established in June 2015, when Vistin Pharma AS acquired the B2B business of Weifa AS.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-04 08:00 |
Notice of Dividend Amount
Ex dividend NOK 1.25 today
|
English | 330 bytes | |
| 2025-05-23 09:22 |
Report Publication Announcement
Financial calendar
|
English | 464 bytes | |
| 2025-05-23 09:22 |
Quarterly Report
Finansiell kalender
|
Norwegian | 448 bytes | |
| 2025-05-22 12:59 |
Declaration of Voting Results & Voting Rights Announcements
Vistin Pharma ASA: Minutes from the annual general meeting 2025
|
English | 897.7 KB | |
| 2025-05-22 12:59 |
AGM Report
Vistin Pharma ASA: Minutes from the annual general meeting 2025
|
English | 736 bytes | |
| 2025-05-22 09:56 |
Declaration of Voting Results & Voting Rights Announcements
Disclosure of voting rights at AGM in Vistin Pharma ASA
|
English | 963 bytes | |
| 2025-05-07 13:30 |
Board/Management Change
Vistin Pharma ASA (VISTN): Update from the Election Committee
|
English | 1.3 KB | |
| 2025-05-06 13:03 |
Directors' Dealings
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
|
English | 168.6 KB | |
| 2025-05-06 13:03 |
Directors' Dealings
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
|
English | 172.1 KB | |
| 2025-05-06 13:03 |
Directors' Dealings
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
|
English | 217.6 KB | |
| 2025-05-06 13:03 |
Directors' Dealings
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
|
English | 1.6 KB | |
| 2025-04-29 09:30 |
General Meeting Notice
Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025
|
English | 1.4 MB | |
| 2025-04-29 09:30 |
Remuneration Report
Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025
|
English | 204.8 KB | |
| 2025-04-29 09:30 |
Annual Report
Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025
|
English | 5.9 MB | |
| 2025-04-29 09:30 |
AGM Report
Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025
|
English | 89.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP | |
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biofarm S.A. | Romania | BIO | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI |